International Society for Pharmacoepidemiology in Action: Advancing Public Health Through Evidence‐Based Advocacy

Abstract

Key Points Public health faces increasingly complex challenges for pharmacoepidemiology: monitoring and evaluating the safety and effectiveness of medicines in real‐world populations, predicting and responding to emerging diseases and outbreaks, overcoming inequities in drug access and outcomes, managing risks from widespread medication use, and countering misinformation about treatments. These challenges are further intensified by financial constraints and shifting geopolitical pressures. Scientific and professional organizations such as the International Society for Pharmacoepidemiology (ISPE) play a critical advocacy role. ISPE advocates for the effective translation of scientific evidence into policy and healthcare practice. This is driven by purposeful, sustained efforts that bridge evidence and action across health systems and stakeholders around the globe.